PUBLISHER: IMARC | PRODUCT CODE: 1540833
PUBLISHER: IMARC | PRODUCT CODE: 1540833
The global bariatric surgery devices market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032.
Bariatric surgery devices refer to the clinical equipment used for conducting bariatric procedures. These procedures aid in weight loss by restricting the amount of food that the stomach can hold and causing malabsorption of nutrients. They also aid in enhancing the production of gut hormones that reduce appetite and provide the feeling of satiety. Some of the common assisting and implantable devices used during this type of surgery include stapling devices, vessel sealing devices, suturing devices, trocars, adjustable gastric bands, gastric balloons, electrical stimulators, etc.
The increasing prevalence of various lifestyle disorders, such as obesity, diabetes and cardiovascular diseases (CVDs), is one of the key factors driving the growth of the market. Owing to the sedentary lifestyle habits and unhealthy dietary patterns of the majority of the population across the globe, there has been a significant increase in the instances of weight-related problems, which is escalating the need for bariatric surgeries. Furthermore, the growing preference for minimally invasive (MI) bariatric procedures and devices that eliminate the need for large incisions and cause minimal postoperative stress have also provided a boost to the market growth. Various advancements, such as the development of devices with improved cosmetic results and minimal pain, is acting as another growth-inducing factor. In addition to this, improvements in the surgical procedures, such as Primary Obesity Surgery Endoluminal (POSE), Laparoscopic Greater Curvature Plication (LGCP) and Hand-Assisted Laparoscopic Surgery (HALS), are also creating a positive impact on the market. Other factors, including the increasing health consciousness among the masses, along with the adoption of surgical robots, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global bariatric surgery devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on procedure type, device type, procedure, application and end-user.
Minimally Invasive Surgical Procedures
Non-Invasive Surgical Procedures
Assisting Devices
Stapling Devices
Energy Based Vessel Sealing Devices
Suturing Devices
Trocars
Clip Appliers
Others
Implantable Devices
Gastric Bands
Electrical Stimulators
Gastric Balloons
Transpyloric Shuttle
Others
Sleeve Gastrectomy
Adjustable Gastric Banding
Roux-en-Y Gastric Bypass
Biliopancreatic Diversion with Duodenal Switch
Others
Weight Loss
Hereditary Disease
Other Disorders
Bariatric Surgery Clinics
Hospitals
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Apollo Endosurgery Inc., GI Dynamics, Intuitive Surgical Inc., Johnson & Johnson Services Inc., Medtronic Inc., Olympus Corporation, Reach Surgical Inc., Reshape Lifesciences Inc., Spatz Fgia Inc., TransEnterix Inc., USGI Medical Inc., etc.